Found: 1
Select item for more details and to access through your institution.
Coadministration of epigallocatechin-3-gallate (EGCG) and caffeine in low dose ameliorates obesity and nonalcoholic fatty liver disease in obese rats.
- Published in:
- 2019
- By:
- Publication type:
- journal article